VEGFA and neoplasm: Moreover, clofibrate reducedthe levels of circulating VEGF in tumor-bearing mice [49], while bezafibrate, anotherPPARα ligand, decreased the number ofintestinal polyps in ApcMin/+ mice possibly by lowering serum levelof triglycerides and upregulating lipoprotein lipase synthesis[27, 51].